Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
15.72 USD | +3.42% | +1.81% | -2.84% |
Financials (USD)
Sales 2024 * | 655M | Sales 2025 * | 718M | Capitalization | 2.01B |
---|---|---|---|---|---|
Net income 2024 * | -72M | Net income 2025 * | -51M | EV / Sales 2024 * | 3.5 x |
Net Debt 2024 * | 286M | Net Debt 2025 * | 272M | EV / Sales 2025 * | 3.17 x |
P/E ratio 2024 * |
-27.6
x | P/E ratio 2025 * |
-40
x | Employees | 2,100 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 98.79% |
Latest transcript on NeoGenomics, Inc.
1 day | +3.42% | ||
1 week | +1.16% | ||
Current month | +0.77% | ||
1 month | -2.54% | ||
3 months | -23.32% | ||
6 months | +26.57% | ||
Current year | -2.84% |
Managers | Title | Age | Since |
---|---|---|---|
Chris Smith
CEO | Chief Executive Officer | 61 | 22-08-14 |
Lynn Tetrault
CHM | Chairman | 61 | 15-06-11 |
Jeffrey Sherman
DFI | Director of Finance/CFO | 58 | 22-12-06 |
Members of the board | Title | Age | Since |
---|---|---|---|
Bruce Crowther
BRD | Director/Board Member | 72 | 14-10-21 |
Michael Kelly
BRD | Director/Board Member | 67 | 20-07-14 |
Chris Smith
CEO | Chief Executive Officer | 61 | 22-08-14 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
1.43% | 17 M€ | -0.46% | ||
0.97% | 11 M€ | -6.03% | - | |
0.29% | 2 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
24-03-28 | 15.72 | +3.42% | 654,428 |
24-03-27 | 15.2 | +0.26% | 787,191 |
24-03-26 | 15.16 | +2.71% | 808,742 |
24-03-25 | 14.76 | -2.96% | 613,629 |
24-03-22 | 15.21 | -1.49% | 639,911 |
Delayed Quote Nasdaq, March 28, 2024 at 04:30 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-2.84% | 1.94B | |
-8.32% | 9.16B | |
-9.54% | 3.67B | |
+39.95% | 3.57B | |
-4.12% | 2.59B | |
-12.21% | 2.27B | |
-16.85% | 1.66B | |
-25.37% | 1.53B | |
-7.98% | 1.09B | |
+2.71% | 1.06B |